Uricosuric agents

From WikiMD.org
Jump to navigation Jump to search

Uricosuric Agents

Uricosuric agents (pronounced: yoo-rih-ko-SUR-ik AY-jents) are a class of drugs that increase the excretion of uric acid in the urine, thus reducing the concentration of uric acid in the blood. They are primarily used in the treatment of gout, a condition characterized by high levels of uric acid in the blood.

Etymology

The term "uricosuric" is derived from the Latin words "urica" meaning "uric acid" and "surere" meaning "to cast out". The term "agent" is derived from the Latin word "agens" meaning "a thing that produces or causes".

Mechanism of Action

Uricosuric agents work by inhibiting the reabsorption of uric acid in the kidney. This leads to an increase in the excretion of uric acid in the urine, thereby reducing the concentration of uric acid in the blood.

Examples

Examples of uricosuric agents include Probenecid, Sulfinpyrazone, and Benzbromarone. These drugs are often used in combination with other medications to treat gout.

Side Effects

Common side effects of uricosuric agents include nausea, vomiting, and diarrhea. In rare cases, these drugs can cause serious side effects such as kidney stones and anemia.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski